ICLR - ICON Public Limited Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
130.97
+0.09 (+0.07%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close130.88
Open131.41
Bid125.10 x 900
Ask158.00 x 900
Day's Range128.52 - 131.55
52 Week Range116.50 - 155.33
Volume214,569
Avg. Volume291,320
Market Cap7.069B
Beta (3Y Monthly)0.83
PE Ratio (TTM)22.24
EPS (TTM)5.89
Earnings DateMay 1, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est154.69
Trade prices are not sourced from all markets
  • Do Hedge Funds Love ICON Public Limited Company (ICLR)?
    Insider Monkey2 days ago

    Do Hedge Funds Love ICON Public Limited Company (ICLR)?

    "Market conditions are changing. The continued rise in interest rates suggests we are in the early stages of a bond bear market, which could intensify as central banks withdraw liquidity. The receding tide of liquidity will start to reveal more rocks beyond what has been exposed in emerging markets so far, and the value of […]

  • Shareholders Are Thrilled That The ICON (NASDAQ:ICLR) Share Price Increased 213%
    Simply Wall St.5 days ago

    Shareholders Are Thrilled That The ICON (NASDAQ:ICLR) Share Price Increased 213%

    The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But on a lighter note, a good company can see its share price rise well over 100%. For instance, t...

  • Markit12 days ago

    See what the IHS Markit Score report has to say about ICON PLC.

    ICON PLC NASDAQ/NGS:ICLRView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for ICLR with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ICLR. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $187 million over the last one-month into ETFs that hold ICLR are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Business Wire2 months ago

    ICON Wins Multiple Categories in 2019 CRO Leadership Awards

    ICON plc, (ICLR) a global provider of drug development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, has won awards across several categories in the annual CRO Leadership Awards. ICON received 2019 CRO Leadership Awards in five categories, each further divided into three groups – Big Pharma, Small Pharma, and Overall.

  • GlobeNewswire2 months ago

    Report: Developing Opportunities within Amazon, Prospect Capital, Alliance Data, Duke Realty, Stellus Capital Investment, and ICON — Future Expectations, Projections Moving into 2019

    NEW YORK, Feb. 27, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of ICLR earnings conference call or presentation 21-Feb-19 2:00pm GMT

    Full Year 2018 ICON PLC Earnings Call

  • What Should We Expect From ICON Public Limited Company’s (NASDAQ:ICLR) Earnings In The Next Couple Of Years?
    Simply Wall St.2 months ago

    What Should We Expect From ICON Public Limited Company’s (NASDAQ:ICLR) Earnings In The Next Couple Of Years?

    Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! ICON Public Limited Company's (NASDAQ:ICLR) latest earnings update in DecemberRead More...

  • Icon PLC (ICLR) Q4 2018 Earnings Conference Call Transcript
    Motley Fool2 months ago

    Icon PLC (ICLR) Q4 2018 Earnings Conference Call Transcript

    ICLR earnings call for the period ending December 31, 2018.

  • GlobeNewswire2 months ago

    MolecularMD is acquired by ICON

    PORTLAND, Ore. and CAMBRIDGE, Mass., Feb. 21, 2019 -- MolecularMD Corporation, a  molecular diagnostic specialty laboratory that enables the development and commercialisation.

  • Icon PLC (ICLR) Beats Q4 Earnings and Revenue Estimates
    Zacks2 months ago

    Icon PLC (ICLR) Beats Q4 Earnings and Revenue Estimates

    Icon PLC (ICLR) delivered earnings and revenue surprises of 1.25% and 0.47%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press2 months ago

    Icon PLC: 4Q Earnings Snapshot

    On a per-share basis, the Dublin-based company said it had net income of $1.62. The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research ...

  • Business Wire2 months ago

    ICON Reports Fourth Quarter and Full Year 2018 Results

    Highlights

  • Icon PLC (ICLR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
    Zacks2 months ago

    Icon PLC (ICLR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    Icon PLC (ICLR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Business Wire2 months ago

    ICON Launches New Drug Safety Reporting Solution that Ensures Compliance through Automation

    ICON plc, (ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the release of a new drug safety reporting solution based on an innovative cloud-based system, featuring automated and configurable business rules. The solution ensures compliance in an increasingly complex regulatory environment and enables the sponsor to gain visibility into the safety profile of an investigational product throughout its lifecycle. Using regulatory intelligence from 80 countries, the system is configured with date-stamped decision rules.

  • What Should We Expect From ICON Public Limited Company’s (NASDAQ:ICLR) Earnings In The Next 12 Months?
    Simply Wall St.3 months ago

    What Should We Expect From ICON Public Limited Company’s (NASDAQ:ICLR) Earnings In The Next 12 Months?

    In September 2018, ICON Public Limited Company (NASDAQ:ICLR) released its earnings update. Generally, analyst forecasts appear to be conservative, with earnings growth rate expected to be 17% next year, which Read More...

  • Business Wire3 months ago

    ICON Issues Financial Guidance for Full Year 2019

    ICON plc (ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced its financial guidance for the year ended December 31, 2019. For the full year 2019 revenue is expected to be in the range of $2,735 - $2,835 million, representing growth of 5.2 – 9.0% and earnings per share is expected to be in the range of $6.69 - $6.89, representing growth of 10.6 – 13.9%.

  • ICON Public Limited Company (NASDAQ:ICLR): Commentary On Fundamentals
    Simply Wall St.4 months ago

    ICON Public Limited Company (NASDAQ:ICLR): Commentary On Fundamentals

    As an investor, I look for investments which does not compromise one fundamental factor for another. By this I mean, I look at stocks holistically, from their financial health to Read More...

  • AMN or ICLR: Which Is the Better Value Stock Right Now?
    Zacks4 months ago

    AMN or ICLR: Which Is the Better Value Stock Right Now?

    AMN vs. ICLR: Which Stock Is the Better Value Option?

  • Hedge Funds Are Crazy About ICON Public Limited Company (ICLR)
    Insider Monkey4 months ago

    Hedge Funds Are Crazy About ICON Public Limited Company (ICLR)

    While the market driven by short-term sentiment influenced by uncertainty regarding the future of the interest rate environment in the US, declining oil prices and the trade war with China, many smart money investors are keeping their optimism regarding the current bull run, while still hedging many of their long positions. However, as we know, […]

  • Is ICON Public Limited Company (NASDAQ:ICLR) As Strong As Its Balance Sheet Indicates?
    Simply Wall St.5 months ago

    Is ICON Public Limited Company (NASDAQ:ICLR) As Strong As Its Balance Sheet Indicates?

    Small and large cap stocks are widely popular for a variety of reasons, however, mid-cap companies such as ICON Public Limited Company (NASDAQ:ICLR), with a market cap of US$7.9b, often Read More...